Semin intervent Radiol 2024; 41(06): 595-600
DOI: 10.1055/s-0044-1800847
Review Article

Update on Existing and Upcoming Branched and Fenestrated Thoracic Aortic Arch Stent Grafts

Alexander A. Brescia
1   Division of Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
,
Zachary J. Wanken
2   Section of Vascular Surgery, Division of General Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
,
J. Westley Ohman*
2   Section of Vascular Surgery, Division of General Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
,
Puja Kachroo*
1   Division of Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
,
On Behalf of the Washington University Collaborative for Aortic Research (WashU-CAR)› Institutsangaben
Preview

Abstract

Conventional management of thoracic aortic arch aneurysm and dissection with aneurysmal degeneration remains open surgical repair. However, multiple branched and fenestrated endograft systems offer promise for hybrid or total endovascular treatment of aortic arch pathology. Two zone 0 solutions involving an aortic arch with innominate branch and ascending aorta components are contemporarily in trial: the Gore thoracic branch endoprosthesis and ascending stent graft in the ARISE II Trial (W. L. Gore & Associates, Newark, Delaware) and the NEXUS Arch Stent Graft System (Endospan Ltd., Herzliya, Israel). Both device systems require a debranching procedure prior to endovascular treatment. Patients deemed appropriate for endovascular treatment with acute pathology or not qualifying for one of these trial devices may undergo homemade single or multiple fenestrated physician-modified endovascular grafts or in situ laser fenestration of aortic arch grafts with branch stenting to treat arch pathology. Ultimately, a durable total endovascular solution must achieve comparable or superior outcomes compared with open surgical repair, at significantly lower impact to patients. Branched and fenestrated endovascular treatments for aortic arch pathology require further investigation and follow-up to determine early, mid, and long-term outcomes including mortality, stroke, and endoleak requiring reintervention.

* J.W.O. and P.K. contributed equally and are co-senior authors.




Publikationsverlauf

Artikel online veröffentlicht:
04. April 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA